$Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council$

Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council

The meeting of experts, concerning the treatment of thyroid cancer was held in Moscow in June 2016. The aim of the meeting was unsolved tasks in the field of therapy of the patients with radioactive iodine-refractory differentiated thyroid cancer. Nowadays, this group of patients still has a poor pr...

Full description

Bibliographic Details
Main Authors:	P O Rumyantsev, V A Gorbunova, S O Podvyaznikov, N V Zhukov, P A Isaev, V V Krylov, A M Mudunov, A A Rodichev, E K Shavarova
Format:	Article
Language:	Russian
Published:	IP Habib O.N. 2016-09-01
Series:	Современная онкология
Subjects:	differentiated thyroid cancer radioactive iodine-refractory lenvatinib
Online Access:	https://modernonco.orscience.ru/1815-1434/article/viewFile/27085/pdf

Similar Items

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
by: Yasuko Hyogo, et al.
Published: (2018-11-01)

Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis
by: Youwen Zhu, et al.
Published: (2022-07-01)

Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model
by: Kensuke Suzuki, et al.
Published: (2022-08-01)

Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
by: Christos Cortas, et al.
Published: (2023-12-01)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
by: Angelica Schmidt, et al.
Published: (2017-02-01)

Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer
by: Gianoukakis AG, et al.
Published: (2016-05-01)

Management of hyperthyroidism with radioactive iodine
by: T Premprapha, et al.
Published: (2006-08-01)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
by: Yuanna Ling, et al.
Published: (2023-07-01)

Impact of lithium on radioactive iodine therapy for hyperthyroidism
by: Brahmanandam Lingudu, et al.
Published: (2014-01-01)

Lithium therapy: an unusual cause of elevated and diffuse radioactive iodine uptake.
by: Ebenezer A Nyenwe, et al.
Published: (2008-10-01)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
by: Lina Liu, et al.
Published: (2022-05-01)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
by: Jae Hoon Chung
Published: (2013-09-01)

APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
by: Sarah Siraj, et al.
Published: (2022-03-01)

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
by: Francesca Collina, et al.
Published: (2019-06-01)

Removal of Radioactive Iodine Using Silver/Iron Oxide Composite Nanoadsorbents
by: Mah Rukh Zia, et al.
Published: (2021-02-01)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
by: Hongxiu Luo, et al.
Published: (2022-09-01)

68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
by: Lisa H. de Vries, et al.
Published: (2020-03-01)

Radioactive Iodine Therapy and Glucose Tolerance
by: Roghaieh Samadi, et al.
Published: (2017-04-01)

Selection of a carrying agent for obtaining radioactive methyliodide vapors under dynamic conditions
by: Alexander V. Obruchikov, et al.
Published: (2021-08-01)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
by: Ji Min Oh, et al.
Published: (2022-03-01)

Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
by: Yuyang Ze, et al.
Published: (2022-12-01)

Progress in Re-differentiating Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
by: ZHANG Yaqi, et al.
Published: (2022-10-01)

The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma
by: Qin Wan, et al.
Published: (2024-04-01)

Control of iodine in the nuclear industry
Published: (1973)

Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report
by: Mahmut Büyükşimşek, et al.
Published: (2018-03-01)

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer
by: Selina K. Wong, et al.
Published: (2019-10-01)

A case of propylthiouracil-induced antineutrophilic cytoplasmic antibody-positive vasculitis successfully treated with radioactive iodine
by: C. Bes, et al.
Published: (2013-07-01)

Is postoperative radioactive iodine associated with a survival advantage among…
by: Hamed Rasha Hamdy
Published: (2017-06-01)

Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid
by: Jain Ankit, et al.
Published: (2009-06-01)

Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma
by: Alberto Signore, et al.
Published: (2023-05-01)

Predictive Value of Clinical and Pathological Characteristics for Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma: A 16-year Retrospective Study
by: Jinyan Chai, et al.
Published: (2022-06-01)

Historical aspects and modern concepts in the treatment of patients with differentiated thyroid cancer, refractory to radioactive iodine therapy
by: E. V. Borodavina, et al.
Published: (2022-02-01)

Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients
by: Rui-Ting Hu, et al.
Published: (2020-05-01)

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
by: Qian Yang, et al.
Published: (2023-01-01)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
by: Sun Hwa Kim, et al.
Published: (2013-03-01)

Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia
by: Mengistu HS, et al.
Published: (2022-04-01)

Ultrasound and Sialendoscopy Findings in Radioactive Iodine–Induced Sialadenitis: Comparative Analysis and Possible Impact on Management
by: Michael Koch, et al.
Published: (2024-01-01)

Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
by: Xiaoran Mei, et al.
Published: (2021-05-01)

Silver Nanomaterial-Immobilized Desalination Systems for Efficient Removal of Radioactive Iodine Species in Water
by: Ha Eun Shim, et al.
Published: (2018-08-01)

Ultrasound combined with Ki-67 to construct the prognostic model for radioactive iodine therapy outcomes in Graves’ disease patients
by: Yuegui Wang, et al.
Published: (2024-01-01)